NIAID Banner Logo Image

Opportunistic Infections Citation List: April 26 - May 9, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Purification, Molecular Cloning, and Antimicrobial Activity of Peptides from the Skin Secretion of the Black-spotted Frog, Rana nigromaculata. Li, A., Y. Zhang, C. Wang, G. Wu, and Z. Wang. World Journal of Microbiology & Biotechnology, 2013. [Epub ahead of print]. PMID[23632907].

[PubMed]. OI_0426-050913.


2. A Comparative Study of Anti-candida Activity and Phenolic Contents of the Calluses from Lythrum salicaria L. In Different Treatments. Manayi, A., S. Saeidnia, M.A. Faramarzi, N. Samadi, S. Jafari, M. Vazirian, A. Ghaderi, T. Mirnezami, A. Hadjiakhoondi, M.R. Ardekani, and M. Khanavi. Applied Biochemistry and Biotechnology, 2013. 170(1): p. 176-184. PMID[23494219].

[PubMed]. OI_0426-050913.


3. Enhanced Inhibition of Aspergillus niger on Sedge (Lepironia articulate) Treated with Heat-cured Lime Oil. Matan, N., N. Matan, and S. Ketsa. Journal of Applied Microbiology, 2013. [Epub ahead of print]. PMID[23617888].

[PubMed]. OI_0426-050913.


4. Antifungal Agents from Pseudallescheria boydii SNB-CN73 Isolated from a Nasutitermes Sp. Termite. Nirma, C., V. Eparvier, and D. Stien. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[23627396].

[PubMed]. OI_0426-050913.


5. Antifungal Activity of Ferulago capillaris Essential Oil against Candida, Cryptococcus, Aspergillus and Dermatophyte Species. Pinto, E., K. Hrimpeng, G. Lopes, S. Vaz, M.J. Goncalves, C. Cavaleiro, and L. Salgueiro. European Journal of Clinical Microbiology & Infectious Diseases, 2013. [Epub ahead of print]. PMID[23619574].

[PubMed]. OI_0426-050913.


6. Synthesis and Antifungal Activity of the Novel Triazole Derivatives Containing 1,2,3-Triazole Fragment. Yu, S., N. Wang, X. Chai, B. Wang, H. Cui, Q. Zhao, Y. Zou, Q. Sun, Q. Meng, and Q. Wu. Archives of Pharmacal Research, 2013. [Epub ahead of print]. PMID[23640383].

[PubMed]. OI_0426-050913.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

7. Rapid in Vivo Assessment of Drug Efficacy against Mycobacterium tuberculosis Using an Improved Firefly Luciferase. Andreu, N., A. Zelmer, S.L. Sampson, M. Ikeh, G.J. Bancroft, U.E. Schaible, S. Wiles, and B.D. Robertson. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23633686].

[PubMed]. OI_0426-050913.


8. Three Antimycobacterial Metabolites Identified from a Marine-Derived Streptomyces Sp. MS100061. Chen, C., J. Wang, H. Guo, W. Hou, N. Yang, B. Ren, M. Liu, H. Dai, X. Liu, F. Song, and L. Zhang. Applied Microbiology and Biotechnology, 2013. 97(9): p. 3885-3892. PMID[23324803].

[PubMed]. OI_0426-050913.


9. Transition Metal-alpha-amino acid Complexes with Antibiotic Activity against Mycobacterium Spp. Karpin, G., J.S. Merola, and J.O. Falkinham, 3rd. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23650159].

[PubMed]. OI_0426-050913.


10. Syntheses and Antimycobacterial Activities of [(2S,3R)-2-(Amino)-4-(arenesulfonamido)-3-hydroxy-1-phenylbutane Derivatives. Moreth, M., C.R. Gomes, M.C. Lourenco, R.P. Soares, M.N. Rocha, C.R. Kaiser, M.V. de Souza, S.M. Wardell, and J.L. Wardell. Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23627296].

[PubMed]. OI_0426-050913.


11. Drug Testing in Mouse Models of Tuberculosis and Nontuberculous mycobacterial Infections. Nikonenko, B.V. and A.S. Apt. Tuberculosis, 2013. 93(3): p. 285-290. PMID[23491715].

[PubMed]. OI_0426-050913.


12. Design, Synthesis and Anti-tuberculosis Activity of 1-Adamantyl-3-heteroaryl Ureas with Improved in Vitro Pharmacokinetic Properties. North, E.J., M.S. Scherman, D.F. Bruhn, J.S. Scarborough, M.M. Maddox, V. Jones, A. Grzegorzewicz, L. Yang, T. Hess, C. Morisseau, M. Jackson, M.R. McNeil, and R.E. Lee. Bioorganic & Medicinal Chemistry, 2013. 21(9): p. 2587-2599. PMID[23498915].

[PubMed]. OI_0426-050913.


13. Quinolones for Mycobacterial Infections. Rubinstein, E. and Y. Keynan. International Journal of Antimicrobial Agents, 2013. [Epub ahead of print]. PMID[23643393].

[PubMed]. OI_0426-050913.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

14. A Plasmodium Falciparum Screening Assay for Anti-gametocyte Drugs Based on Parasite Lactate Dehydrogenase Detection. D'Alessandro, S., F. Silvestrini, K. Dechering, Y. Corbett, S. Parapini, M. Timmerman, L. Galastri, N. Basilico, R. Sauerwein, P. Alano, and D. Taramelli. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23645588].

[PubMed]. OI_0426-050913.


15. Male and Female P. falciparum Mature Gametocytes Show Different Responses to Antimalarial Drugs. Delves, M.J., A. Ruecker, U. Straschil, J. Lelievre, S. Marques, M.J. Lopez-Barragan, E. Herreros, and R.E. Sinden. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID [23629698].

[PubMed]. OI_0426-050913.


16. Antiprotozoal Activity of Khaya anthotheca, (Welv.) C.D.C. A Plant Used by Chimpanzees for Self-Medication. Obbo, C.J., B. Makanga, D.A. Mulholland, P.H. Coombes, and R. Brun. Journal of Ethnopharmacology, 2013. 147(1): p. 220-223. PMID[23501156].

[PubMed]. OI_0426-050913.


17. Antimalarial Potential of China 30 and Chelidonium 30 in Combination Therapy against Lethal Rodent Malaria Parasite: Plasmodium berghei. Rajan, A. and U. Bagai. Journal of Complementary & Integrative Medicine, 2013. 10(1): p. 1-8. PMID[23652641].

[PubMed]. OI_0426-050913.

ANTIPROTOZOAL COMPOUNDS

18. The Effect of Kinase, Actin, Myosin and Dynamin Inhibitors on Host Cell Egress by Toxoplasma gondii. Caldas, L.A., S.H. Seabra, M. Attias, and W. de Souza. Parasitology International, 2013. [Epub ahead of print]. PMID[23624149].

[PubMed]. OI_0426-050913.


19. Design, Synthesis and Molecular Modeling of Novel Pyrido[2,3-d]pyrimidine Analogs as Antifolates: Application of Buchwald-Hartwig Aminations of Heterocycles. Gangjee, A., O.A. Namjoshi, S. Raghavan, S.F. Queener, R.L. Kisliuk, and V. Cody. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23627352].

[PubMed]. OI_0426-050913.

Citations from the ISI Web of Knowledge Listings for O.I.

20. Novel 2-(2-Benzylidenehydrazinyl)benzo d Thiazole as Potential Antitubercular Agents. Bairwa, V.K. and V.N. Telvekar. Combinatorial Chemistry & High Throughput Screening, 2013. 16(3): p. 244-247. ISI[000317057600009].

[WOS]. OI_0426-050913.


21. Expression, Characterization and Inhibition of Toxoplasma gondii 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase. Cai, G.B., L.S. Deng, J. Xue, S.N.J. Moreno, B. Striepen, and Y.C. Song. Bioorganic & Medicinal Chemistry Letters, 2013. 23(7): p. 2158-2161. ISI[000316642900049].

[WOS]. OI_0426-050913.


22. Structural Basis for the Inhibition of Mycobacterium tuberculosis L,D-Transpeptidase by Meropenem, a Drug Effective against Extensively Drug-resistant Strains. Kim, H.S., J. Kim, H.N. Im, J.Y. Yoon, D.R. An, H.J. Yoon, J.Y. Kim, H.K. Min, S.J. Kim, J.Y. Lee, B.W. Han, and S.W. Suh. Acta Crystallographica Section D-Biological Crystallography, 2013. 69: p. 420-431. ISI[000316742700012].

[WOS]. OI_0426-050913.


23. Bactericidal and Fungicidal Activity of Methanolic Extracts of Heracleum persicum Desf. Ex Fischer against Some Aquatic and Terrestrial Animal Pathogens. Kousha, A. and M. Bayat. International Journal of Pharmacology, 2012. 8(7): p. 652-656. ISI[000316977500007].

[WOS]. OI_0426-050913.


24. Inhibition of Protein Splicing of Mycobacterium tuberculosis RecA Intein by Pd Complexes. Liu, Y., Q. Wu, Y.C. Zheng, and Y.Z. Liu. Chemical Journal of Chinese Universities-Chinese, 2013. 34(2): p. 272-276. ISI[000317085400003].

[WOS]. OI_0426-050913.


25. Paepalanthus Spp: Antimycobacterial Activity of Extracts, Methoxylated Flavonoids and Naphthopyranone Fractions. Moreira, R.R.D., G.Z. Martins, R. Pietro, D.N. Sato, F.R. Pavan, S.R.A. Leite, W. Vilegas, and C.Q.F. Leite. Revista Brasileira de Farmacognosia, 2013. 23(2): p. 268-272. ISI[000316963100010].

[WOS]. OI_0426-050913.


26. Potent Growth Inhibitory Activity of (+/-)-Platencin Towards Multi-drug-resistant and Extensively Drug-resistant Mycobacterium tuberculosis. Moustafa, G.A.I., S. Nojima, Y. Yamano, A. Aono, M. Arai, S. Mitarai, T. Tanaka, and T. Yoshimitsu. MedChemComm, 2013. 4(4): p. 720-723. ISI[000316868900013].

[WOS]. OI_0426-050913.


27. Novel Semisynthetic Antibiotics from Caprazamycins A-G: Caprazene Derivatives and Their Antibacterial Activity. Takahashi, Y., M. Igarashi, T. Miyake, H. Soutome, K. Ishikawa, Y. Komatsuki, Y. Koyama, N. Nakagawa, S. Hattori, K. Inoue, N. Doi, and Y. Akamatsu. Journal of Antibiotics, 2013. 66(3): p. 171-178. ISI[000316790000010].

[WOS]. OI_0426-050913.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2023